Additional file 1: Table S1. of Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series

Authors: Atsuko Kurosaki (805823)
Atsuyuki Kurashima (3551789)
Hiroaki Sugiura (190855)
Hiromu Tanaka (3551783)
Hiroshi Fujiwara (236227)
Ho Namkoong (3551780)
Kazuma Yagi (3551795)
Kozo Morimoto (3551798)
Makoto Ishii (229384)
Naoki Hasegawa (1698301)
Sadatomo Tasaka (729727)
Shoji Suzuki (1424941)
Takanori Asakura (3551786)
Tomoko Betsuyaku (87406)
Tomoyasu Nishimura (3551777)
Yoshihiko Hoshino (259654)
Yoshitake Yamada (3551792)
Publication date
Publisher
Doi

Abstract

Comparison of patient characteristics between patients receiving AMK and patients not receiving AMK (DOCX 14 kb

Last time updated on 12/02/2018

Last time updated on 12/02/2018